CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Supernus Pharmaceuticals Inc  (SUPN)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 


Supernus Pharmaceuticals Inc

SUPN's Fundamental analysis



You need to upgrade your Flash Player

Looking into Supernus Pharmaceuticals Inc growth rates, revenue grew by 30.28 % in I. Quarter 2017 from the same quarter a year ago. Ranking at No. 737

Supernus Pharmaceuticals Inc's averge rate of year on year quarterly revenue increase, is at1387.48 %.

Major Pharmaceutical Preparations industry recorded growth of revenues by 13.27 %

Supernus Pharmaceuticals Inc's net income grew by 113.41 % in I. Quarter 2017 year on year, below company average,

More on SUPN's Growth




Supernus Pharmaceuticals Inc
current PE on trailing twelve month basis is below Major Pharmaceutical Preparations industry average.

Supernus Pharmaceuticals Inc PEG ratio is at 0.05 , above Major Pharmaceutical Preparations industry PEG average of -28.7.
Company
23.37
PE TTM    
Industry
53.43
PE TTM    
Company's Price to Sales ratio is at 9.77.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 22.15.

Supernus Pharmaceuticals Inc Price to Book Ratio is at 10.83 higher than Indusry Avg. of 4.98, and higher than S&P 500 Avg. of 4.48

More on SUPN's Valuation





 Market Capitalization (Millions $) 2,232
 Shares Outstanding (Millions) 53
 Employees -
 Revenues (TTM) (Millions $) 228
 Net Income (TTM) (Millions $) 97
 Cash Flow (TTM) (Millions $) 40
 Capital Exp. (TTM) (Millions $) -23
You need to upgrade your Flash Player
 Total Debt (Millions $) 3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover Ratio (TTM) 6.05
 Tangible Book Value (Per Share $) 3.35

Profitability

Supernus Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in I. Quarter 2017 to 29.16 % from 26.13 % in IV. Quarter.

Supernus Pharmaceuticals Inc net profit margin of 17.88 % is currently ranking no. 25 in Major Pharmaceutical Preparations industry, ranking no. 60 in Healthcare sector and number 869 in S&P 500.

More on SUPN's Key Ratios
You need to upgrade your Flash Player

You need to upgrade your Flash Player
  Ratio
  Working Capital Ratio (MRQ) 1.83
  Total Debt to Equity (MRQ) 0.02
  Tangible Leverage Ratio (MRQ) 0.66
  Asset Turnover Ratio (TTM) 0.8
  Inventory Turnover Ratio (TTM) 0.74


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com